CoChat

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction

Hohnloser, Stefan H., Kuck, Karl Heinz, Dorian, Paul, Roberts, Robin S., Hampton, John R., Hatala, Robert, Fain, Eric, Gent, Michael, Connolly, Stuart J. · 2004 · New England Journal of Medicine

The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs in patients early after myocardial infarction is unknown. METHODS: We conducted the Defibrillator in Acute Myocardial Infarction Trial, a randomized, open-label comparison of ICD therapy (in 332 patients) and no ICD therapy (in 342 patients) 6 to 40 days after a myocardial infarction. We enrolled patients who had reduced left ventricular function (left ventricular ejection fraction, 0.35 or less) and impaired cardiac autonomic function (manifested as depressed heart-rate variability or an elevated average 24-hour heart rate on Holter monitoring). The primary outcome was mortality from any cause. Death from arrhythmia was a predefined secondary outcome. RESULTS: During a mean (+/-SD) follow-up period of 30+/-13 months, there was no difference in overall mortality between the two treatment groups: of the 120 patients who died, 62 were in the ICD group and 58 in the control group (hazard ratio for death in the ICD group, 1.08; 95 percent confidence interval, 0.76 to 1.55; P=0.66). There were 12 deaths due to arrhythmia in the ICD group, as compared with 29 in the control group (hazard ratio in the ICD group, 0.42; 95 percent confidence interval, 0.22 to 0.83; P=0.009). In contrast, there were 50 deaths from nonarrhythmic causes in the ICD group and 29 in the control group (hazard ratio in the ICD group, 1.75; 95 percent confidence interval, 1.11 to 2.76; P=0.02). CONCLUSIONS: Prophylactic ICD therapy does not reduce overall mortality in high-risk patients who have recently had a myocardial infarction. Although ICD therapy was associated with a reduction in the rate of death due to arrhythmia, that was offset by an increase in the rate of death from nonarrhythmic causes.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa041489

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. Myerburg RJ, 1992, Circulation, 85, I
  2. Zuanetti G, 1999, Eur Heart J, 1, H52
  3. Mantel N, 1966, Cancer Chemother Rep, 50, 163

Cited by

See all 1,519

Metadata

Authors
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J.
Affiliations
  • Goethe University Frankfurt (DE)
  • St. Michael's Hospital (CA)
  • University of Nottingham (GB)
  • McMaster University (CA)
Venue
New England Journal of Medicine
Published
2004-12-09
Volume
351
Issue
24
Pages
2481-2488
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2109205604
Cited by
1,519
References
22
Citations by year
2026: 23 · 2025: 24 · 2024: 32 · 2023: 39 · 2022: 50 · 2021: 54 · 2020: 53 · 2019: 59 · 2018: 52 · 2017: 93 · 2016: 67 · 2015: 75 · 2014: 70 · 2013: 93 · 2012: 96
FWCI
52.71
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
implantable cardioverter-defibrillator, acute myocardial infarction, all-cause mortality, left ventricular dysfunction, heart rate variability
MeSH terms
Adult, Aged, Arrhythmias, Cardiac, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.